AstraZeneca has signed a deal worth up to $5.2bn to work with a Chinese biotech company using AI to develop new treatments for chronic diseases.

Veteran Nigerian comedian and social commentator, Alibaba, has raised alarm over the skyrocketing cost of contesting for ...

Russians are increasingly struggling to repay loans taken out during the credit boom of 2023 to mid-2024. Source: The Moscow ...

Last year saw 99,000 personal snatch thefts - including stolen mobile phones and handbags - the highest figure in more than ...

Premier Peter Malinauskas wants to charge ahead with contracts for a $2bn Osborne nuclear shipyard, despite the AUKUS ...

A major dual-carriageway has reopened after two decades of roadworks amounting to £2 billion in building costs.

Investor Day, Hippo unveiled a three-year strategic roadmap, setting 2028 financial targets that include gross written ...

The announcement builds on AZ's announcement earlier this year that it will invest $2.5 billion in an R&D facility in China, ...

The government’s spending review, revealed this week, offers little in the way of support for beleaguered small businesses, says the Fed. The Fed’s ...

Mohammad Jamei, CBI Director of Economic Policy, breaks down what the 2025 Spending Review means for UK business ...

Wales's transport secretary Ken Skates admitted the project had "not been without its challenges" and thanked local residents ...

Key sectors such as retail (-6.1%) and automotive (-4.0%) are set to cut ad spend this year, while ad spend growth across ...